Pathogenic and physiological autoantibodies in the central nervous system (Q38020957)

27 August 2017

title

Pathogenic and physiological autoantibodies in the central nervous system (English)

1 reference

27 August 2017

1 reference

0 references

5

Richard Dodel

1 reference

27 August 2017

Maike Gold

1

1 reference

27 August 2017

Refik Pul

series ordinal

2

1 reference

27 August 2017

Jan-Philipp Bach

series ordinal

3

1 reference

27 August 2017

Martin Stangel

series ordinal

4

1 reference

27 August 2017

publication date

1 July 2012

1 reference

27 August 2017

published in

Immunological Reviews

1 reference

27 August 2017

volume

248

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

68-86

1 reference

Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The natural antibody repertoire of sharks and humans recognizes the potential universe of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Naturally occurring B-cell autoreactivity: a critical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Humoral autoimmunity as a mediator of CNS repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Invited article: human natural autoantibodies in the treatment of neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoantibodies associated with diseases of the CNS: new developments and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

How do immune cells overcome the blood-brain barrier in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

21 January 2018

Natural autoantibodies.

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Peripheral B cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoantibody selection and production in early human life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Progenitors for Ly-1 B cells are distinct from progenitors for other B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

CD5: a safeguard against autoimmunity and a shield for cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20 CD27 CD43 CD70−

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

21 January 2018

B-1 B cell development

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Regulation of B1 cell migration by signals through Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Defective B cell tolerance checkpoints in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

A small CD11b( ) human B1 cell subpopulation stimulates T cells and is expanded in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Predominant autoantibody production by early human B cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Receptor editing is the main mechanism of B cell tolerance toward membrane antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

BCMA is essential for the survival of long-lived bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Naturally occurring auto-antibodies in homeostasis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF-kappaB) signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Determinants of Human B Cell Migration Across Brain Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Subunit arrangement and function in NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

NMDA receptors: recent insights and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Glycine as a neurotransmitter in the forebrain: a short review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Molecular structure and function of the glycine receptor chloride channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoimmunity to gephyrin in Stiff-Man syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Bridging the cleft at GABA synapses in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Receptors, gephyrin and gephyrin-associated proteins: novel insights into the assembly of inhibitory postsynaptic membrane specializations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Structure and regulation of voltage-gated Ca2 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Ablation of P/Q-type Ca(2 ) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Voltage-gated potassium channels as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Gene associated with seizures, autism, and hepatomegaly in an Amish girl

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The expression of TAG-1 in glial cells is sufficient for the formation of the juxtaparanodal complex and the phenotypic rescue of tag-1 homozygous mutants in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

A common protein interaction domain links two recently identified epilepsy genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The aquaporins, blueprints for cellular plumbing systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The molecular basis of water transport in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Pathogenic T cell responses against aquaporin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

NMO-IgG and Devic's neuromyelitis optica: a French experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Homer: a protein that selectively binds metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Differential expression of Homer family proteins in the developing mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Rab2 utilizes glyceraldehyde-3-phosphate dehydrogenase and protein kinase C{iota} to associate with microtubules and to recruit dynein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Inhibition of glyceraldehyde-3-phosphate dehydrogenase activity by antibodies present in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Neurofascin as a novel target for autoantibody-mediated axonal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antibody to myelin-associated glycoprotein produces central nervous system demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Paraneoplastic Syndromes Involving the Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Tolerance to the neuron-specific paraneoplastic HuD antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Paraneoplastic encephalomyelopathies: pathology and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Anti-CV2 autoantibodies and paraneoplastic neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Amphiphysin autoimmunity: paraneoplastic accompaniments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Journal of Neurochemistry special issue on Alzheimer's disease: 'amyloid cascade hypothesis--20 years on'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoreactive-Aβ antibodies promote APP β-secretase processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Naturally Occurring Autoantibodies against β-Amyloid: Investigating Their Role in Transgenic Animal andIn VitroModels of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoantibody-catalyzed hydrolysis of amyloid beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

21 January 2018

The many faces of tau

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Method of identifying natural antibodies for remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

Neuron-binding human monoclonal antibodies support central nervous system neurite extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.2012.01128.X

10.1111/J.1600-065X.2012.01128.X

21 January 2018

Identifiers

DOI

1 reference

release_ypuf4fbpr5cenergf6g6nhehry

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ypuf4fbpr5cenergf6g6nhehry

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference